Skip to Main ContentSkip to FooterSkip to Search
Main menu
  1. Home
  2.  » 
  3. About Us
  4.  » 
  5. Corporate Responsibility
  6.  » Environment

Corporate Responsibility


Minimizing the environmental impact of our operations is essential to promoting healthy communities that thrive on a clean and sustainable planet.

At Catalent, our environmental sustainability efforts focus on mitigating the impacts of our operations on climate, water, and waste, as well as complying with environmental regulations. We know that our key stakeholders share our values of operational excellence and environmental responsibility, and we are working diligently to make progress against our goals.

In 2021, we committed to the Science Based Targets initiative and set a new goal of reducing Scope 1 and Scope 2 emissions by 42% by 2030.

We achieved our initial carbon reduction goal ahead of time through site-based energy reduction projects and transitioning the majority of our sites to renewable electricity. Soon after, we signed a letter of commitment with the Science-Based Target initiative (SBTi), joining a growing list of companies setting actionable, science-based greenhouse gas emission reduction targets to limit global warming.


  • 42% reduction in Scope 1 and Scope 2 carbon emissions by fiscal 2030
  • Water intensity reduction to 500 cubic meters per million dollars of revenue (m3/M$) by fiscal 2024
  • No residual active pharmaceutical ingredients (API) above Predicted No Effect Concentration (PNEC) in wastewater by fiscal 2024
  • Zero waste sent to landfill by fiscal 2024

    Our approach to environmental management

    Our sustainability culture is fueled by robust Environmental Health, Safety and Sustainability (EHS&S) policies and systems. We are committed to managing the environment with care, which supports the integration of responsibility and sustainability into our operations and our decision-making process. The EHS Policy, signed by our President and COO, outlines our company- wide environmental stewardship objectives, commitments, and our expectations for employees to comply.

    Across every aspect of our work globally, we are streamlining operating standards, procedures, and training through an ISO14001-accredited environmental management system. In fiscal 2021, we increased the scope of our accreditation to 46 sites, up from 33 in fiscal 2020.

    How we measure and drive progress

    Our sites report environmental data through a central platform and our sustainability progress is tracked with an internal sustainability scorecard by the EHS&S Team. The data guides our environmental strategy, helping our sites improve operational best practices and minimize our footprint.

    BSI ISO14001 Environmental Management Certification Badge EMS647952

    Reducing our carbon footprint

    Catalent is a science-based and science-driven company: As such, we recognize the urgency to operate responsibly, and we will continue working towards minimizing our impact on the planet.

    Energy efficiency helps us meet our carbon reduction goals

    Our carbon reduction strategy involves:

    • Sourcing renewable electricity.
    • Investing in energy efficiency projects.
    • Replacing on-site equipment with more energy-efficient models.

    We’re proud that in fiscal 2021, 20 Catalent sites were powered by 100% renewable electricity, including 14 sites that transitioned during fiscal 2021. In early fiscal 2022, we transitioned another 15 sites. In other words, 35 Catalent sites are currently being powered by 100% renewable electricity.

    In fiscal 2021, we conducted 114 site-based energy efficiency projects. These projects are designed to help our team identify and implement new ways to be more efficient and sustainable in our day-to-day work.

    Compared to our fiscal 2018 baseline, our total direct and indirect emissions have decreased 20.1%, surpassing our goal to achieve a 15% reduction by 2023.

    You can learn more and access our energy and emissions data in our latest CR report.


    At Catalent, we work to minimize water use and eliminate the risk of adverse environmental effects from wastewater discharge. With a goal of reducing our water intensity to $500m³ per million dollars of revenue by fiscal 2024, we are optimizing manufacturing processes and conservation initiatives at our sites. For instance, we are currently reviewing water use linked to equipment cleaning, as an opportunity to reduce water usage across the network.

    In fiscal 2021, our total water use was 1.9 million m³, unchanged from fiscal 2020.

    In our latest Corporate Responsibility Report, you can learn more and access our water usage, water source, and intensity data.

    You can learn more in our latest CR report.


    As a member of the pharmaceutical sector, we regularly manage and dispose of products that include active pharmaceutical ingredients, or APIs, on behalf of our customers. Some of our activities—such as cleaning manufacturing equipment—may introduce APIs into wastewater, which must be properly disposed so as not to harm the environment. Catalent currently follows all regulatory requirements for wastewater disposal and our new target pushes us to a water disposal standard beyond the legal requirements.

    Our goal is that by fiscal 2024, all sites will discharge wastewater with API concentrations below predicted no-effect concentration (PNEC) levels.

    Improving waste management

    Manufacturing life-saving and life-enhancing products also produces waste. We are committed to reducing our waste generation and maintaining compliance with all regulatory requirements for the disposal of hazardous and non-hazardous waste. At Catalent sites globally, we limit the volume of nonessential material brought onto our sites, segregate waste streams, and divert waste from the landfill. Hazardous waste is disposed of through incineration, as required per regulations of our sector. You can learn more and access our waste management data in our latest CR report.

    Some of our most recent waste recycling initiatives include increasing the amount of excess gelatin that we recycle or reuse. For example, in fiscal 2021, we diverted 19% of the total gelatin by-product we generated during the year.

    Image of tractor trailer transporting softgel waste.

    Shipment of gelatin waste, a by-product of Softgel manufacturing process at our Benheim site, to third parties who recycle the material into new products.


    As of fiscal 2021, 18 of 33 sites no longer send waste to landfills. To reach our fiscal 2024 goal of sending zero waste to landfill, we are implementing actions and plans at our remaining sites to divert landfill material to recycling, reuse, or incineration. You can learn more and access our waste diversion data on our latest CR report.


    As a member of the Pharmaceutical Supply Chain Initiative (PSCI)—a group of companies from the healthcare and pharmaceutical sector dedicated to improving the industry’s social and environmental impacts—we are engaging with peers in our industry on best practices in social and environmental programming.

    Our suppliers are critical to the operation of our business. In fiscal 2021, our internal Procurement team distributed social and environmental assessments to select suppliers and conducted an assessment of human rights risks in our operations and supply chain. The results of the various assessments will guide our approach to scaling our responsible supplier audit program in the future.


    Catalent team members contribute to building Catalent’s culture of corporate responsibility & sustainability. Green Teams bring employees together, share best practices and raise sustainability awareness at our sites and in our communities.

    For more information on Corporate Responsibility & Sustainability at Catalent, email us or follow #catalentcares on social media.